2-{2-[3-(4-methoxyphenyl)-5-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Chemical Structure Depiction of
2-{2-[3-(4-methoxyphenyl)-5-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
2-{2-[3-(4-methoxyphenyl)-5-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Compound characteristics
Compound ID: | E239-0002 |
Compound Name: | 2-{2-[3-(4-methoxyphenyl)-5-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide |
Molecular Weight: | 498.6 |
Molecular Formula: | C28 H26 N4 O3 S |
Smiles: | Cc1ccc(cc1)C1CC(c2ccc(cc2)OC)=NN1C1=NC(C(CC(Nc2ccccc2)=O)S1)=O |
Stereo: | MIXTURE OF STEREOISOMERS |
logP: | 5.2237 |
logD: | 5.2237 |
logSw: | -5.1137 |
Hydrogen bond acceptors count: | 8 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 66.516 |
InChI Key: | PMZIJCWGJMPKOH-UHFFFAOYSA-N |